ViraQuest

ViraQuest is a biotechnology custom service provider and reagent manufacturer specializing in adenovirus production services. Founded in 2000 and based in North Liberty, Iowa, the company utilizes its patented RAPAd® technology platform to produce custom adenovirus particles in as little as three weeks. ViraQuest offers a comprehensive suite of services, including the amplification, isolation, and titering of existing viral particles, as well as subcloning services to insert cDNA sequences into viral constructs. In February 2024, ViraQuest was acquired by Janel Corporation and subsequently merged into its life sciences subsidiary, Antibodies Incorporated, where it continues to operate as a specialized brand supporting academic, non-profit, and commercial researchers globally.